NCT05494684

Brief Summary

This randomized controlled trial (RCT) study aims to evaluate the effectiveness of multisensoral nature-based intervention compare to standard care in relieving anxiety, fear and pain in hospitalized child aged 5 to 9 years and parent's anxiety and satisfaction during venous blood sampling. The assessment uses different measures to assess child's anxiety, fear, pain and parent's anxiety and satisfaction during venous blood sampling.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
53

participants targeted

Target at P25-P50 for not_applicable anxiety

Timeline
8mo left

Started Aug 2025

Typical duration for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress54%
Aug 2025Dec 2026

First Submitted

Initial submission to the registry

July 29, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

August 10, 2022

Completed
3 years until next milestone

Study Start

First participant enrolled

August 1, 2025

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

April 4, 2025

Status Verified

March 1, 2025

Enrollment Period

1.4 years

First QC Date

July 29, 2022

Last Update Submit

March 31, 2025

Conditions

Keywords

ChildrenNature-based InterventionVenipuncture

Outcome Measures

Primary Outcomes (1)

  • Anxiety measured with mYPAS (the modifield Yale preoperative anxiety scale). An external observer assesses the child's anxiety before blood sampling on video.

    The mYPAS (modifield Yale preoperative anxiety scale) was developed for external observers to assess a child's anxiety before blood sampling and is suitable for measuring anxiety in children aged 2-16 years. The Modifield Yale preoperative scale measures the child's activity, voice, emotional expression and parental need (1-4/4, 1-6/6, 1-4/4, 1-4/4 points). Each item is scored separately and the total score is multiplied by 20. The lowest score for child anxiety is 1 and the highest score is 100. The scale has been tested for validity and relational validity (Kain X.N. et al. 1997).

    Before blood sampling

Secondary Outcomes (5)

  • Fear measured with CFS (Children Fear Scale). Child and parent assessment of fear during blood sampling.

    During blood sampling

  • Pain measured with FAS (Facial Affective Scale). Child and parent assessment of pain during blood sampling.

    During blood sampling

  • Parent's anxiety with STAI-Y1 (The State-Trait Anxiety Inventory). Parent self-assessment of own anxiety before blood sampling.

    Before blood sampling

  • Parent's satisfaction with VAS (A Visual Analogue Scale). Parent self-assessment of own satisfaction after blood sampling.

    After blood sampling

  • Child's anxiety, fear and pain with physiological measures: Heart Rate (HR, beats per minute) during blood sampling.

    During blood sampling

Study Arms (2)

Intervention Group

EXPERIMENTAL

Children and parents receive a multisensoral nature-based intervention during venous blood sampling.

Other: Multisensoral Nature-based Intervention

Control Group

NO INTERVENTION

The control group receives the usual standard care during venous blood sampling

Interventions

The intervention includes a multi-sensory nature experience using natural materials and a virtually created natural environment.

Intervention Group

Eligibility Criteria

Age5 Years - 9 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • The child is aged between 5 and 9 years old
  • The child has a long-term illness (such as diabetes or rheumatism)
  • The child has previous experience of venous blood sampling
  • The child's level of development is age-appropriate (such as, the child is cared for at home or in day care/day nursery or attends school in the same level as the other children)
  • Child and parent understand and speak the Finnish language

You may not qualify if:

  • The child has a diagnosis of abnormal neurological development (such as, a child has difficulty understanding spoken language or expressing emotions)
  • The child has chronic pain that has lasted more than 3 months and requires strong painkillers (opiates).
  • The child undergoes an examination or treatment during a check-up at the outpatient clinic that requires medical treatment similar to anesthesia
  • The child is taking a sedative medication.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oulu Univeristy

Oulu, Finland

Location

Related Publications (7)

  • Kain ZN, Mayes LC, Cicchetti DV, Bagnall AL, Finley JD, Hofstadter MB. The Yale Preoperative Anxiety Scale: how does it compare with a "gold standard"? Anesth Analg. 1997 Oct;85(4):783-8. doi: 10.1097/00000539-199710000-00012.

    PMID: 9322455BACKGROUND
  • McMurtry CM, Noel M, Chambers CT, McGrath PJ. Children's fear during procedural pain: preliminary investigation of the Children's Fear Scale. Health Psychol. 2011 Nov;30(6):780-8. doi: 10.1037/a0024817. Epub 2011 Aug 1.

    PMID: 21806301BACKGROUND
  • McKinley S, Stein-Parbury J, Chehelnabi A, Lovas J. Assessment of anxiety in intensive care patients by using the Faces Anxiety Scale. Am J Crit Care. 2004 Mar;13(2):146-52.

    PMID: 15043242BACKGROUND
  • McGrath PA, Seifert CE, Speechley KN, Booth JC, Stitt L, Gibson MC. A new analogue scale for assessing children's pain: an initial validation study. Pain. 1996 Mar;64(3):435-443. doi: 10.1016/0304-3959(95)00171-9.

    PMID: 8783307BACKGROUND
  • Nguyen TN, Nilsson S, Hellstrom AL, Bengtson A. Music therapy to reduce pain and anxiety in children with cancer undergoing lumbar puncture: a randomized clinical trial. J Pediatr Oncol Nurs. 2010 May-Jun;27(3):146-55. doi: 10.1177/1043454209355983.

    PMID: 20386063BACKGROUND
  • Nilsson S, Finnstrom B, Morelius E, Forsner M. The facial affective scale as a predictor for pain unpleasantness when children undergo immunizations. Nurs Res Pract. 2014;2014:628198. doi: 10.1155/2014/628198. Epub 2014 Mar 5.

    PMID: 24734174BACKGROUND
  • Abu-Saad H. Assessing children's responses to pain. Pain. 1984 Jun;19(2):163-71. doi: 10.1016/0304-3959(84)90836-4.

    PMID: 6462728BACKGROUND

MeSH Terms

Conditions

Anxiety DisordersPainPersonal Satisfaction

Condition Hierarchy (Ancestors)

Mental DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Study Officials

  • Saija Huhtala

    Oulu University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The children blood sampling will be videotaped. The principal investigator videos the blood sampling, and then external observer assesses the child's anxiety (mYPAS=Modifield Yale preoperative anxiety scale) on video. The video camera is pre-installed in the blood sampling room and positioned so that it does not attract attention.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomization of the children participating in the study will be carried out using the Stratified Block Randomization-on method, which allows randomization in two groups, according to age, as follows: group 1 (5-6 years old) and group 2 (7-9 years old). This is to ensure that the intervention and control groups have the same number of children of the same age and do not differ in their starting level. The randomization lists are made by a statistician.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 29, 2022

First Posted

August 10, 2022

Study Start

August 1, 2025

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

April 4, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations